Kaikai Zhao
机构：Academy of Medical Sciences, Zhengzhou University, Shandong Tumor Hospital, 175th Hospital of People's Liberation Army, Second Affiliated Hospital of Xi'an Jiaotong University, Shandong First Medical University · ORCID：0000-0001-5556-2877
发表论文 53 篇 · 总被引 709 次 · h-index 12
代表论文
- Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer (2024 · BMC Cancer · 被引 39)
- Global, regional, and national burden of esophageal cancer using the 2019 global burden of disease study (2025 · Scientific Reports · 被引 14)
- RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature (2024 · Scientific Reports · 被引 11)
- An inhalable nanoparticle enabling virulence factor elimination and antibiotics delivery for pneumococcal pneumonia therapy (2024 · Journal of Controlled Release · 被引 9)
- Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single‑center retrospective study (2025 · Journal of Neuro-Oncology · 被引 5)
- PortNet: Achieving lightweight architecture and high accuracy in lung cancer cell classification (2025 · Heliyon · 被引 4)